CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	5 Months Ended
	Feb. 10, 2024	Feb. 11, 2023
Cash flows from operating activities:
Net income	$ 1,108,493	$ 1,015,862
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property and equipment	245,192	222,964
Other non-cash (income) charges	(16,000)	91,000
Amortization of debt origination fees	5,551	3,922
Deferred income taxes	5,998	(4,697)
Share-based compensation expense	45,961	42,379
Changes in operating assets and liabilities:
Accounts receivable	18,364	22,273
Merchandise inventories	(198,425)	(161,546)
Accounts payable and accrued expenses	(17,062)	(111,311)
Income taxes	96,282	87,400
Other, net	(29,968)	(60,185)
Net cash provided by operating activities	1,264,386	1,148,061
Cash flows from investing activities:
Capital expenditures	(490,807)	(259,234)
Purchase of marketable debt securities	(14,038)	(14,000)
Proceeds from sale of marketable debt securities	12,626	3,450
Investment in tax credit equity investments	(42,522)	(12,070)
Other, net	(9,253)	11,846
Net cash used in investing activities	(543,994)	(270,008)
Cash flows from financing activities:
Net (payments of) proceeds from commercial paper	(32,228)	227,600
Proceeds from issuance of debt	1,000,000	1,000,000
Repayment of debt		(300,000)
Net proceeds from sale of common stock	98,338	72,758
Purchase of treasury stock	(1,709,034)	(1,799,997)
Repayment of principal portion of finance lease liabilities	(41,459)	(40,572)
Other, net	(8,462)	(4,510)
Net cash used in financing activities	(692,845)	(844,721)
Effect of exchange rate changes on cash	(505)	3,574
Net increase in cash and cash equivalents	27,042	36,906
Cash and cash equivalents at beginning of period	277,054	264,380
Cash and cash equivalents at end of period	$ 304,096	$ 301,286